1. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression. Issue 2 (February 2022) Authors: Neuen, Brendon L.; Tighiouart, Hocine; Heerspink, Hiddo J.L.; Vonesh, Edward F.; Chaudhari, Juhi; Miao, Shiyuan; Chan, Tak Mao; Fervenza, Fernando C.; Floege, Jürgen; Goicoechea, Marian; Herrington, William G.; Imai, Enyu; Jafar, Tazeen H.; Lewis, Julia B.; Li, Philip Kam-Tao; Locatelli, Francesc... Journal: Journal of the American Society of Nephrology Issue: Volume 33:Issue 2(2022) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials. (1st February 2021) Authors: Yu, Jie; Zhou, Zien; Mahaffey, Kenneth W.; Matthews, David R.; Neuen, Brendon L.; Heerspink, Hiddo J.L.; Jardine, Meg J.; Li, JingWei; Perkovic, Vlado; Neal, Bruce; Arnott, Clare Journal: International journal of cardiology Issue: Volume 324(2021) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease. Issue 2 (February 2022) Authors: Waijer, Simke W.; Sen, Taha; Arnott, Clare; Neal, Bruce; Kosterink, Jos G.W.; Mahaffey, Kenneth W.; Parikh, Chirag R.; de Zeeuw, Dick; Perkovic, Vlado; Neuen, Brendon L.; Coca, Steven G.; Hansen, Michael K.; Gansevoort, Ron T.; Heerspink, Hiddo J.L. Journal: Clinical journal of the American Society of Nephrology Issue: Volume 17:Issue 2(2022) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Balloon inflation time in angioplasty of dialysis access stenosis. Issue 4 (20th August 2014) Authors: Neuen, Brendon L.; Grainer, Frank; Mantha, Murty L. Journal: Hemodialysis international Issue: Volume 18:Issue 4(2014) Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial. Issue 18 (8th February 2021) Authors: Ye, Nan; Jardine, Meg J.; Oshima, Megumi; Hockham, Carinna; Heerspink, Hiddo J.L.; Agarwal, Rajiv; Bakris, George; Schutte, Aletta E.; Arnott, Clare; Chang, Tara I.; Górriz, Jose L.; Cannon, Christopher P.; Charytan, David M.; de Zeeuw, Dick; Levin, Adeera; Mahaffey, Kenneth W.; Neal, Bruce; Poll... Journal: Circulation Issue: Volume 143:Issue 18(2021) Page Start: 1735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis. Issue 10 (9th June 2022) Authors: Li, Chao; Yu, Jie; Hockham, Carinna; Perkovic, Vlado; Neuen, Brendon L.; Badve, Sunil V.; Houston, Lauren; Lee, Vivian Y. J.; Barraclough, Jennifer Y.; Fletcher, Robert A.; Mahaffey, Kenneth W.; Heerspink, Hiddo J. L.; Cannon, Christopher P.; Neal, Bruce; Arnott, Clare Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 10(2022) Page Start: 1927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program. (17th February 2021) Authors: Yu, Jie; Arnott, Clare; Neuen, Brendon L.; Heersprink, Hiddo L.; Mahaffey, Kenneth W.; Cannon, Christopher P.; Khan, Sadiya S.; Baldridge, Abigail S.; Shah, Sanjiv J.; Huang, Yuli; Li, Chao; Figtree, Gemma A.; Perkovic, Vlado; Jardine, Meg J.; Neal, Bruce; Huffman, Mark D. Journal: ESC heart failure Issue: Volume 8:Number 2(2021) Page Start: 1482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program. Issue 15 (9th October 2018) Authors: Neuen, Brendon L.; Ohkuma, Toshiaki; Neal, Bruce; Matthews, David R.; de Zeeuw, Dick; Mahaffey, Kenneth W.; Fulcher, Greg; Desai, Mehul; Li, Qiang; Deng, Hsiaowei; Rosenthal, Norm; Jardine, Meg J.; Bakris, George; Perkovic, Vlado Journal: Circulation Issue: Volume 138:Issue 15(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial. Issue 6 (7th March 2022) Authors: Barraclough, Jennifer Y.; Yu, Jie; Figtree, Gemma A.; Perkovic, Vlado; Heerspink, Hiddo J. L.; Neuen, Brendon L.; Cannon, Christopher P.; Mahaffey, Kenneth W.; Schutte, Aletta E.; Neal, Bruce; Arnott, Clare Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 6(2022) Page Start: 1072 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis. Issue 5 (4th March 2019) Authors: Toyama, Tadashi; Neuen, Brendon L.; Jun, Min; Ohkuma, Toshiaki; Neal, Bruce; Jardine, Meg J.; Heerspink, Hiddo L.; Wong, Muh Geot; Ninomiya, Toshiharu; Wada, Takashi; Perkovic, Vlado Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 5(2019) Page Start: 1237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗